Efficacy of Mecobalamin Tablets Combined with Troxerutin in the Treatment of NSCLC Chemotherapy-Induced Peripheral Neuropathy

Table 1

Baseline characteristics of the two groups in this study.

	Control group (n = 60)	Research group (n = 60)	t/χ^2
Gender (n)
Male	39	38	0.036	0.749
Female	21	22
Age (years)	60.29 ± 5.38	60.04 ± 6.01	0.614	0.427
BMI (kg/m^2)	22.67 ± 2.17	22.71 ± 2.24	0.725	0.305
Karnofsky performance status (points)	94.28 ± 7.41	94.88 ± 8.12	0.831	0.207
TNM stage (n)
II	18	20	0.154	0.695
III–IV	42	40
Differentiation (n)
Low	8	9	0.170	0.918
Middle	30	31
High	22	20
Cancer type (n)
Adenocarcinoma	35	38	0.315	0.575
Squamous cell carcinoma	25	22
Previous treatment
Previous surgery	41	39	0.150	0.699
Previous radiation therapy	6	7	0.086	0.769
Previous targeted therapy	5	4	0.120	0.729